lundi 18 mai 2015

Onco Actu du 18 mai 2015 - Spécial ASCO

5.5.1 ASCO (général)

Jumpstart ASCO '15 With This Quick List of Hot Research Abstracts [TheStreet]

ASCO 2015: pre-meeting presscast [The OBR Blog]

New Cancer Treatment and Prevention Studies Signal Major Advances for Children and Adults [ASCO] ASCO (général) - Industriels

Myriad Showcases Its Pioneering Research at the 2015 ASCO Annual Meeting [Myriad]

Caris Life Sciences Announces Presentation of Comprehensive Tumor Profiling Research at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting [Caris Life Sciences]

ARIAD Announces Data Presentations at the 2015 ASCO Annual Meeting [ARIAD]

Merck to Present Data at ASCO that Illustrate How the Company is Tackling Difficult - to - Treat Cancers [Merck]

Bristol-Myers Squibb to Present Data at 2015 American Society of Clinical Oncology (ASCO) Annual Meeting that Demonstrate the Promise of its Broad Immuno-Oncology Portfolio Across Solid Tumors and Blood Cancers Including Multiple Myeloma [BMS]

Merck KGaA, Darmstadt, Germany, and Pfizer to Present Data at ASCO for Avelumab, an Investigational Anti-PD-L1 Antibody [Pfizer]

AstraZeneca to update on progress with immuno-oncology pipeline and combination treatments at ASCO 2015 [AstraZeneca]

Puma Biotechnology Announces Publication of Abstracts for the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting [Puma]

ImmunoGen, Inc. Announces Clinical Data Presentations at Upcoming ASCO Annual Meeting [ImmunoGen]

Bayer to Present Latest Oncology Research at ASCO 2015 [Bayer]

The ASCO roundup: Thumbs down for Puma, up for Roche, mixed for Bristol-Myers [FierceBiotech] ASCO (général) - Académiques

Dana-Farber researchers focus on breakthrough cancer research and care at 2015 ASCO conference [Dana-Farber Cancer Institute]

Variations in liver cancer attributable to hepatitis virus variations [MD Anderson Cancer Center]

Tumor sequencing study highlights benefits of profiling healthy tissue as well [MD Anderson Cancer Center]

5.5.10 ASCO (hémato)

ASCO '15 -- Bristol, Abbvie Immune-Boosting Drug Lowers Progression Risk in Multiple Myeloma [TheStreet]

Bristol and AbbVie’s Experimental Drug Delayed Progression of Blood Cancer [Wall Street Journal]

Bristol, AbbVie drug extends multiple myeloma remission: study [Reuters]

5.5.2 ASCO (sein)

Puma Biotechnology Founder Auerbach Loses $250 Million On Cancer Drug Data [Forbes]

5.5.3 ASCO (prostate)

New hopes for prostate cancer sufferers [The Telegraph]

Earlier chemotherapy extends lives of men with advanced prostate cancer [Cancer Research UK]

5.5.4 ASCO (immunothérapie)

10 Important Checkpoint Inhibitor Cancer Drug Abstracts from ASCO '15 [TheStreet]

5.5.6 ASCO (peau)

Vitamin B3 Prevents New Skin Cancers In Study [Forbes]

Type of B vitamin shown to reduce risk of common skin cancers [Reuters]

Don’t take vitamin B3 to prevent skin cancer – stick with shade [Cancer Research UK]

B Vitamin Is Found to Help People Prone to Some Types of Skin Cancer [NY Times]

5.5.8 ASCO (poumon)

Genentech’s Investigational Medicine Alectinib Shrank Tumors in Nearly Half of People with Specific Type of Lung Cancer [Genentech]

AstraZeneca drug combination on track to fight lung cancer [Reuters]

Roche immunotherapy improves lung cancer survival | Reuters

Boehringer Ingelheim showcases expanding presence in lung cancer at ASCO 2015 with new data including presentation of afatinib* overall survival results for squamous cell carcinoma of the lung [Boehringer Ingelheim]

5.5.9 ASCO (autres organes)

Personalized approach helped cure more children with kidney cancer [Reuters]